Exelon price target raised to $46 from $44 at BMO Capital

BMO Capital raised the firm’s price target on Exelon (EXC) to $46 from $44 and keeps an Outperform rating on the shares ahead of its Q4 results. The firm expects a robust capital plan update focused on incremental transmission spending opportunities that strengthen the company’s 7.5% rate base growth extended through 2028, the analyst tells investors in a research note.